Anti-oxidant and anti-apoptotic effects of luteolin on mice peritoneal macrophages stimulated by angiotensin II

International Immunopharmacology

Volumn 20, Issue 2, 2014, Pages 346-351

  Zhang, Tian ^a   Wu, Wanling ^a   Li, Dongye ^a   Xu, Tongda ^a   Zhu, Hong ^a   Pan, Defeng ^a   Zhu, Shasha ^a   Liu, Yang ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Ang II; Anti oxidant; Apoptosis; Luteolin; Macrophages

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; LUTEOLIN; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; LIPID OXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL CULTURE; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; INBRED MOUSE STRAIN; METABOLISM;

ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELLS, CULTURED; FEMALE; LUTEOLIN; MACROPHAGES, PERITONEAL; MALONDIALDEHYDE; MICE; MICE, INBRED STRAINS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE; VITAMIN E;

EID: 84898939507     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.03.018     Document Type: Article

References (34)

1. A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler Thromb Vasc Biol 29 2009 1419 1423
2. E.A. Van Vre, H. Ait-Oufella, A. Tedgui, and Z. Mallat Apoptotic cell death and efferocytosis in atherosclerosis Arterioscler Thromb Vasc Biol 32 2012 887 893
3. T. Seimon, and I. Tabas Mechanisms and consequences of macrophage apoptosis in atherosclerosis J Lipid Res 50 2009 S382 S387 (Suppl.)
4. M. Karaflou, I. Lambrinoudaki, and G. Christodoulakos Apoptosis in atherosclerosis: a mini-review Mini Rev Med Chem 8 2008 912 918
5. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
6. C.A. Papaharalambus, and K.K. Griendling Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury Trends Cardiovasc Med 17 2007 48 54
7. A. Rojas, H. Figueroa, L. Re, and M.A. Morales Oxidative stress at the vascular wall. Mechanistic and pharmacological aspects Arch Med Res 37 2006 436 448
8. Y.J. Choi, J.S. Kang, J.H. Park, Y.J. Lee, J.S. Choi, and Y.H. Kang et al. Polyphenolic flavonoids differ in their antiapopt otic efficacy in hydrogen peroxide-treated human vascular endothelial cells J Nutr 133 2003 985 991
9. P. Vitaglione, F. Morisco, N. Caporaso, and V. Fogliano Dietary antioxidant compounds and liver health Crit Rev Food Sci Nutr 44 2004 575 586
10. M.C. Kim, S.J. Kim, D.S. Kim, Y.D. Jeon, S.J. Park, and H.S. Lee et al. Vanillic acid inhibits inflammatory mediators by suppressing NF-kappaB in lipopolysaccharide-stimulated mouse peritoneal macrophages Immunopharmacol Immunotoxicol 33 2011 525 532
11. E. Kunisch, R. Fuhrmann, A. Roth, R. Winter, W. Lungershausen, and R.W. Kinne et al. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry Ann Rheum Dis 63 2004 774 784
12. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, and G.D. Simone et al. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 948 954
13. M. Lopez-Lazaro Distribution and biological activities of the flavonoid luteolin Mini Rev Med Chem 9 2009 31 59
14. C.Y. Chen, W.H. Peng, K.D. Tsai, and S.L. Hsu Luteolin suppresses inflammation-associated gene expression by blocking NF-kappa B and AP-1 activation pathway in mouse alveolar macrophages Life Sci 81 2007 1602 1614
15. J.T. Hwang, O.J. Park, Y.K. Lee, M.J. Sung, H.J. Hur, and M.S. Kim et al. Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-kappaB modulation in HepG2 hepatocarcinoma cells Int J Mol Med 28 2011 25 31
16. G. Seelinger, I. Merfort, and C.M. Schempp Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin Planta Med 74 2008 1667 1677
17. W. Wu, D. Li, Y. Zong, H. Zhu, D. Pan, and T. Xu et al. Luteolin inhibits inflammatory responses via p38/MK2/TTP mediated mRNA stability Molecules 18 2013 8083 8094
18. J. Song, K. Liu, J. Yi, D. Zhu, G. Liu, and B. Liu et al. Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium/mithocondrion/caspases-dependent pathway Planta Med 76 2010 433 438
19. L. Qi, H. Pan, D. Li, F. Fang, D. Chen, and H. Sun et al. Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes Eur J Pharmacol 668 2011 201 207
20. F. Fang, D. Li, H. Pan, D. Chen, L. Qi, and R. Zhang et al. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion Pharmacology 88 2011 149 158
21. G.K. Hansson Atherosclerosis - an immune disease: the Anitschkov lecture 2007 Atherosclerosis 202 2009 2 10
22. A. Nobuhiko, E. Suganuma, V.R. Babaev, A. Fogo, L.L. Swift, and M.F. Linton et al. Angiotensin II amplifies macrophage-driven atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 2143 2148
23. R.E. Pratt Angiotensin II and the control of cardiovascular structure J Am Soc Nephrol 10 Suppl. 11 1999 S120 S128
24. G. Schmitz, and M. Grandl Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation Antioxid Redox Signal 9 2007 1499 1518
25. J.L. Johnson, and A.C. Newby Macrophage heterogeneity in atherosclerotic plaques Curr Opin Lipidol 20 2009 370 378
26. M. Usui, and K. Egashira Angiotensin II receptor and oxidative stress Nihon Rinsho 60 2002 1893 1897
27. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int J Biochem Cell Biol 39 2007 44 84
28. G.R. Buettner Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide Anticancer Agents Med Chem 11 2011 341 346
29. J.M. McCord, and I. Fridovich Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) J Biol Chem 244 1969 6049 6055
30. K. Horvathova, I. Chalupa, L. Sebova, D. Tothova, and A. Vachalkova Protective effect of quercetin and luteolin in human melanoma HMB-2 cells Mutat Res 565 2005 105 112
31. S.S. Huang, S.M. Liu, S.M. Lin, P.H. Liao, R.H. Lin, and Y.C. Chen et al. Antiarrhythmic effect of caffeic acid phenethyl-ester (CAPE) on myocardial ischemia/reperfusion injury in rats Clin Biochem 38 2005 943 947
32. I.H. Chae, K.W. Park, H.S. Kim, and B.H. Oh Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells Clin Chim Acta 341 2004 83 91
33. J.W. Dong, H.F. Zhu, W.Z. Zhu, H.L. Ding, T.M. Ma, and Z.N. Zhou et al. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression Cell Res 13 2003 385 391
34. D. Sun, J. Huang, Z. Zhang, H. Gao, J. Li, and M. Shen et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats PLoS One 7 2012 e33491